How Significant Will Veklury’s Sales Be? Forecasts Show It Is Hard To Tell
Modest Benefits Challenged By WHO Study
Executive Summary
Veklury is now the first US FDA-approved treatment for COVID-19, but its limited benefits means its lifespan as a blockbuster could be short.